How to buy Clearside Biomedical stock (CLSD)

Clearside Biomedical is a biotechnology business based in the US. Clearside Biomedical shares (CLSD) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.95 – an increase of 8.91% over the previous week. Clearside Biomedical employs 30 staff and has a trailing 12-month revenue of around $7.5 million.

Our top picks for where to buy Clearside Biomedical stock

Buy Clearside Biomedical stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Clearside Biomedical stock price (NASDAQ: CLSD)

Use our graph to track the performance of CLSD stocks over time.

Clearside Biomedical shares at a glance

• Key figures

Information last updated 2024-12-26.

Latest market close	$0.95
52-week range	$0.80 - $2.12
50-day moving average more info button	$1.05
200-day moving average more info button	$1.21
Wall St. target price	$6.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.45

Is it a good time to buy Clearside Biomedical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Clearside Biomedical price performance over time

Historical closes compared with the close of $0.93 from 2024-12-26

1 week (2024-12-20)	6.61%
1 month (2024-11-27)	-13.08%
3 months (2024-09-27)	-19.83%
6 months (2024-06-28)	-28.46%

1 year (2023-12-28)	-20.51%
2 years (2022-12-28)	-11.43%
3 years (2021-12-28)	2.72
5 years (2019-12-27)	3.14

Clearside Biomedical financials

Revenue TTM	$7.5 million
Gross profit TTM	$1.1 million
Return on assets TTM	-44.05%
Return on equity TTM	-1310.02%
Profit margin	0%
Book value	$-0.25
Market Capitalization more info button	$70.5 million

TTM: trailing 12 months

Clearside Biomedical share dividends

We're not expecting Clearside Biomedical to pay a dividend over the next 12 months.

Clearside Biomedical share price volatility

Over the last 12 months, Clearside Biomedical's shares have ranged in value from as little as $0.801 up to $2.12. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Clearside Biomedical's is 2.332. This would suggest that Clearside Biomedical's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Clearside Biomedical overview

Clearside Biomedical, Inc. , a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc. , BioCryst Pharmaceuticals, Inc. , and Aura Biosciences.

Frequently asked questions

null
What percentage of Clearside Biomedical is owned by insiders or institutions?
Currently 7.388% of Clearside Biomedical shares are held by insiders and 23.166% by institutions. How many people work for Clearside Biomedical?
Latest data suggests 30 work at Clearside Biomedical. When does the fiscal year end for Clearside Biomedical?
Clearside Biomedical's fiscal year ends in December. Where is Clearside Biomedical based?
Clearside Biomedical's address is: 900 North Point Parkway, Alpharetta, GA, United States, 30005 What is Clearside Biomedical's ISIN number?
Clearside Biomedical's international securities identification number is: US1850631045 What is Clearside Biomedical's CUSIP number?
Clearside Biomedical's Committee on Uniform Securities Identification Procedures number is: 185063104